TrialMedical oncology (Northwood, London, England)2021

Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial.

Yoshinori Imamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.